Abstract
We report a case of a 75-year-old man with a history of a malignant melanoma with massive bilateral adrenal gland metastases diagnosed by F18-FDG-PET/CT after 10 years of negative follow-up.
Similar content being viewed by others
References
Skin cancer: preventing America’s most common cancer. Atlanta Centre for Disease Control and Prevention 2003. http://www.cdc.gov/cancer/nscpep/skin.htm. Accessed February 14, 2009.
Wansaicheong G, Goh J. Adrenal metastases. eMedicine, Omaha, 2002 [cited June 2003]. Available from URL: http://www.emedicine.com/radio/topic17.htm
Brown TJ, Nelson BR. Malignant melanoma: a clinical review. Cutis 1999;63:275–278, 281–4.
Kumar R, Mavi A, Bural G, Alavi A. Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiol Clin N Am 2005;43:23–33.
Seshadri N, Wat J, Balan K. Bilateral adrenal metastases from malignant melanoma: concordant findings on 18F-FDG and 18F-F-DOPA-PET. Eur J Nucl Med Mol Imaging 2006;33: 854–855.
Mays SR, Nelson BR. Current therapy of cutaneous melanoma. Cutis 1999;63:293–298.
Weber J. Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010). Oncologist 2008;13(suppl 4):16–25.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bertagna, F., Biasiotto, G., Rodella, C. et al. Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CT. Jpn J Radiol 27, 392–393 (2009). https://doi.org/10.1007/s11604-009-0358-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-009-0358-8